This study is being done to test the safety and efficacy of the study drug LY3556050 for the
treatment of diabetic peripheral neuropathic pain. This trial is part of the chronic pain
master protocol (H0P-MC-CPMP) which is a protocol to accelerate the development of new
treatments for chronic pain.
If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.